Sitabem Tablet 50/850 Milligrams

Adult dose

This medication is generally taken twice daily with meals, and the dosage should be gradually increased to minimize gastrointestinal adverse reactions due to metformin. 1. For patients not previously treated with metformin: The initial dosage is 50/500 mg, taken twice daily with one tablet per intake, and it can be increased to 50/1000 mg twice daily with one tablet per intake. 2. For patients currently on metformin: Recommended initial dosage...

This drug contains both sitagliptin and metformin and is used for the treatment of type 2 diabetes. During the use of this drug, severe allergic reactions may occur; therefore, if a rash, hives, shortness of breath, or swelling of the face or neck occurs, discontinue immediately and consult a doctor. If symptoms of acute pancreatitis, such as abdominal pain, nausea, or vomiting, appear, discontinue use and seek medical attention. This medication should not be given to patients with poor kidney function, severe infections, dehydration, acute heart failure, or acute myocardial infarction. Temporary discontinuation of this medication is necessary before and after tests involving iodine-based contrast agents, and resuming should only occur after confirming normal kidney function. Pregnant women or those who may become pregnant, as well as breastfeeding women, should not take this medication. Caution is needed due to the risk of hypoglycemia, especially in cases of irregular meals, intense exercise, or concurrent use with other hypoglycemic agents. Regular kidney function and blood tests should be conducted during treatment, especially for the elderly, who need to be more vigilant about changes in kidney function. Excessive alcohol consumption should be avoided while taking this medication, as it may increase the risk of lactic acidosis. If scheduled for surgery or in cases of severe infection or trauma, this medication should be temporarily discontinued and resumed after recovery. In case of an overdose, seek medical attention immediately for appropriate treatment, as some components may be removed through dialysis. Severe joint pain or skin blisters should be reported to a doctor immediately, and medication should be halted if such symptoms occur. This medication may cause gastrointestinal disturbances (diarrhea, nausea, vomiting, abdominal pain) and headache, as well as upper respiratory infections; consultation with a doctor is essential if symptoms worsen. If hypoglycemic symptoms arise, it is crucial to consume fast-acting carbohydrates or glucose immediately, and if symptoms persist, notify healthcare personnel. Patients should monitor their blood glucose and symptoms regularly, and consult healthcare personnel promptly if there are any abnormal signs.

Serious side effects

Hives, angioedema, chest tightness, difficulty breathing, anaphylaxis, Stevens-Johnson syndrome, acute pancreatitis, severe lactic acidosis, acute renal failure, severe edema, joint pain accompanied by severe and disabling symptoms, blistering mucous membrane disorders, severe skin reactions, acute pancreatitis, severe allergic reactions, liver dysfunction (jaundice), acute renal failure, respiratory issues, serious neurological symptoms, severe edema, or urinary abnormalities

Mild side effects

• Diarrhea
• nausea
• vomiting
• abdominal pain
• upper respiratory infection
• nasopharyngitis
• headache
• hypoglycemia
• myalgia
• limb pain

This medication should be stored in a tightly sealed container that allows air circulation, at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness for a longer duration.

Appearance

Pink, oval film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP x 3)]